-
Product Insights
B-Cell Chronic Lymphocytic Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
B-Cell Chronic Lymphocytic Leukemia pipeline market research report provides comprehensive information on the therapeutics under development for B-Cell Chronic Lymphocytic Leukemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for B-Cell Chronic...
-
Product Insights
Leiomyosarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Leiomyosarcoma is an aggressive soft tissue sarcoma derived from smooth muscle cells typically of uterine, gastrointestinal or soft tissue origin. Symptoms include a noticeable lump or swelling, pain, if it presses on nerves or muscles and a blockage in the stomach or intestines or gastrointestinal bleeding if the tumor is located in the abdomen or digestive tract. Predisposing factors include age, chemical exposure and radiation exposure. The Leiomyosarcoma - drugs in development research report provides a comprehensive overview on the...
-
Product Insights
Nasopharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Nasopharyngeal cancer is a rare type of head and neck cancer. It starts in the upper part of throat, behind the nose. This area is called the nasopharynx. The risk factors of nasopharyngeal cancer may include Epstein-Barr virus. Symptoms of nasopharyngeal cancer may include blurry or double vision, difficulty speaking, including hoarseness, ear infections that keep coming back, face pain or numbness, headache, hearing loss, ringing in the ears. The Nasopharyngeal cancer - Drugs in Development research report provides a...
-
Product Insights
Behcet Disease Disease – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Behcet Disease Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Behcet Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Behcet Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also...
-
Product Insights
Epstein-Barr Virus (HHV-4) Infections – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Epstein-Barr Virus (HHV-4) Infections Global Clinical Trials Review, H2, 2020" provides an overview of Epstein-Barr Virus (HHV-4) Infections Clinical trials scenario. This report provides top line data relating to the clinical trials on Epstein-Barr Virus (HHV-4) Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...
-
Product Insights
Behcet Disease Disease – Global Clinical Trials Review, H1, 2020
GlobalData's clinical trial report, “Behcet Disease Global Clinical Trials Review, H1, 2020" provides an overview of Behcet Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Behcet Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...